WGRX — Wellgistics Health Cashflow Statement
0.000.00%
- $43.88m
- $66.74m
- $18.13m
Annual cashflow statement for Wellgistics Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.005 | -2.9 | -6.86 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | — | — | 1.17 |
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.005 | 2.55 | 3.34 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Cash from Operating Activities | 0 | -0.349 | -1.22 |
| Capital Expenditures | — | — | -0.377 |
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | — | — | 0.846 |
| Sale of Business | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | — | — | 0.469 |
| Financing Cash Flow Items | 0 | 0.001 | 1.15 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0 | 0.35 | 1.78 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0 | 0.001 | 1.03 |